Anna Edney
Amgen cholesterol drug wins U.S. approval for some patients
THOUSAND OAKS, Calif. - Amgen Inc. won U.S. approval for its powerful cholesterol-lowering drug Repatha for certain patients, making it the second in a...
Libido pill’s risks have insurers weighing whether to pay
NEW YORK - Health insurers are grappling with the question of whether to cover the new pink pill to treat low libido in women,...
Amgen wins EU approval to be first in new cholesterol drug...
WASHINGTON - Amgen Inc. won approval in the European Union for its drug Repatha, the first regulatory clearance for a new class of powerful...
Amgen cholesterol drug wins panel backing for some patients
WASHINGTON - Amgen Inc.’s Repatha won the backing of a panel of U.S. regulatory advisers for some patients, making it the second in a...
Bracing for biotech copycats, Amgen plans its own imitations
WASHINGTON - At a state-of-the-art facility in Thousand Oaks, Calif., drugmaker Amgen Inc. is perfecting the art of copying others.
The 25,000-square-foot (2,300-square-meter) plant is...
Walgreen says sales reach record as prescription drugs grow
WASHINGTON - Walgreen Co., the largest U.S. pharmacy chain by revenue, said Tuesday that fiscal year sales rose to a record $76.4 billion after...
Looser marijuana restrictions get review by FDA
U.S. regulators are studying whether restrictions on marijuana should be eased, a step toward decriminalizing the drug at the federal level.
The Food and Drug...
Amgen drugs may boost survival after a nuclear attack
WASHINGTON – Amgen Inc.’s Neulasta and Neupogen and a similar blood-boosting drug from Teva Pharmaceutical Industries Ltd. may help people survive after a nuclear...
Most Americans drive while distracted on phones, CDC study finds
WASHINGTON – About seven of 10 Americans talk on their mobile phones while behind the wheel, a dangerous distraction that is more common in...
Health care law cost $3.8 billion in first 10 months to...
WASHINGTON - The U.S. health care law in its first 10 months prompted as much as $3.8 billion in spending and credits, with about...